 |
Dr. Coutinho is executive director of the Infectious Disease Institute at Makerere University in Kampala, Uganda. From 2001 to 2007 he served as executive director of The AIDS Support Organisation of Uganda (TASO), the largest AIDS care and support organisation in sub-Saharan Africa. Prior to joining TASO, he worked in a range of capacities for the Royal Swaziland Sugar Corporation (RSSC) with progressively greater responsibility for community services, focusing especially on HIV. He established holistic prevention and care services, voluntary counselling and testing (VCT), management of opportunistic infections, a tuberculosis clinic, an AIDS clinic, a peer education programme as well as hospital management and palliative care for terminal AIDS patients. These services were implemented using a multisectoral approach that involved schools, communities, churches and unions in an expanded HIV prevention and care programme. He has provided counselling and care to hundreds of AIDS patients in Uganda and Swaziland. Dr. Coutinho was a member of the interim board of the Global Fund to Fight AIDS, Tuberculosis, and Malaria as the fund was established, and he served as the vice chair of the Global Fund Technical Review Panel for two years. He was vice chair of the board of the Regional AIDS Training Network and a member of the strategic advisory group for the WHO HIV/AIDS global strategy. He is currently a member of the scientific committee of the Academic Alliance for HIV/AIDS as well as a board member of the AIDS Information Centre — the largest VCT nongovernmental organisation in Africa. He has published a number of articles on AIDS service provision. He holds an MB ChB and an MSc from Makerere University and an MPH from the University of the Witwatersrand.
 |
Dr. Brookman-Amissah was Ghana’s minister of health from 1996 to 1998. She is currently vice president for Africa at Ipas, a nongovernmental organisation that works to increase women’s ability to exercise their sexual and reproductive rights around the world. Prior to that appointment Dr. Brookman-Amissah served as Ghana’s ambassador to the Netherlands for three years. During her time as minister she introduced health care reform and comprehensive reproductive health services that highlighted the needs of the underprivileged. Dr. Brookman-Amissah was the first woman vice president of the Ghana Medical Association and has been the Commonwealth Medical Association’s representative to the Advisory Committee of the Commonwealth Human Rights Initiative since 2002.
 |
Dr. Corr is a general partner with Celtic Therapeutics Management LLLP, a new product development group. Dr. Corr served as senior vice president for science and technology at Pfizer, Inc, from 2002 to 2006, when he retired. Dr. Corr served as executive vice president, Pfizer Global Research & Development; and president, Worldwide Development. Before joining Pfizer in 2000, he was president of Pharmaceutical Research and Development at Warner-Lambert/Parke-Davis until the merger with Pfizer. He also served as senior vice president, Discovery Research, at Monsanto/Searle. Dr. Corr received his doctorate from Georgetown University School of Medicine and Dentistry. He was a professor in the Department of Medicine (Cardiology) and the Department of Pharmacology and Molecular Biology at Washington University in St. Louis. His research has been published in more than 160 scientific manuscripts. He has also served on or is serving on the editorial board of several journals, including the American Journal of Physiology, Circulation, Circulation Research, Molecular and Cellular Biochemistry, and the Journal of Cardiovascular Electrophysiology. Dr. Corr is a member of the board of governors of the New York Academy of Sciences and the board of regents of Georgetown University.
 |
Dr. Harrison is the managing general partner of Apple Tree Partners, a life sciences venture capital firm. He has invested in life sciences since 1991. Prior to founding Apple Tree, Dr. Harrison was a general partner at Oak Investment Partners and earlier had been a venture partner at Sevin Rosen Funds. His current investments include Structural GenomiX and GeneOS Oy, and his exited investments include ArQule, Coelacanth, Cyrano Sciences, HeartWare Limited (Australia), Informed Access, Ultracision and ViroPharma. Dr. Harrison serves as founding investor, acting CEO and chairman of numerous portfolio companies. He received an AB from Princeton University, an MD and MBA both from Columbia University and completed a surgery internship at New York-Presbyterian Hospital. Dr. Harrison is chairman of the board of trustees of the New York Studio School for Drawing, Painting and Sculpture.
 |
Ambassador Herfkens served as Netherlands minister for Development Cooperation from 1998 to 2002 and has served with some of the most influential multinational organisations in the world. In 2002 UN Secretary-General Kofi Annan appointed Ambassador Herfkens the executive coordinator for the Millennium Development Goals Campaign, where she continues to lead cooperative efforts aimed at lifting developing nations out of poverty and disease. From 1996 to 1998 she served as ambassador extraordinary and plenipotentiary and permanent representative of the Netherlands at the United Nations. Ambassador Herfkens is a member of the World Commission on the Social Dimension of Globalisation. She also served the Netherlands as a member of Parliament, in the Parliamentary Assembly of the Council of Europe, and in the Netherlands Ministry of Foreign Affairs. Ms. Herfkens studied law and economics at Leiden University.
 |
Dr. Kessler is professor of paediatrics at the University of California, San Francisco School of Medicine, where he had also served as dean. He was formerly the dean of the Yale University School of Medicine. Dr. Kessler was commissioner of the U.S. Food and Drug Administration (FDA) from November 1990 until March 1997, appointed first by President George H.W. Bush and reappointed by President Bill Clinton. Dr. Kessler has a wide range of experience in research, clinical medicine, education, administration and the law. He is a 1973 magna cum laude, Phi Beta Kappa graduate of Amherst College. He received his JD degree in 1978 from the University of Chicago Law School, where he was a member of the Law Review. He received his MD degree from Harvard Medical School in 1979, and he did his internship and residency in paediatrics at the Johns Hopkins Hospital. In 1986 he earned an advanced professional certificate from the New York University Graduate School of Business Administration. From 1984 until his FDA appointment, he was the medical director of the Hospital of the Albert Einstein College of Medicine in New York, where he held teaching appointments in the Department of Pediatrics and the Department of Epidemiology and Social Medicine. From 1986 until 1990 Dr. Kessler also taught food and drug law at the Columbia University School of Law in New York. He was a consultant to the U.S. Senate Labor and Human Resources Committee from 1981 until 1984.
 |
Dr. Lewis is Advisor in the World Bank’s Research Department and formerly served as Chief Economist of Human Development during which she oversaw the economic and policy work of the World Bank in the area of human development, encompassing health, education, labor markets, pensions and welfare. She is an expert on the economics of health and health systems and has worked in more than 30 countries. Dr. Lewis led the team that designed the World Bank’s first major HIV project in Brazil in 1993. She has published widely on a variety of topics related to health and population issues in developing and transition countries and has worked at the U.S. Agency for International Development, the Urban Institute, and the Center for Global Development. She holds a Ph.D. in Population Economics from Johns Hopkins University.
 |
Ms. Memela-Khambula is the managing director of Post Bank, which is part of the South African Post Office. She is responsible for leading the state-owned institution to become a bank of choice for underserved communities in urban and rural South Africa. She is also a director in Memela Pratt Associates (MPA), a woman-owned executive search firm. Prior to joining Post Bank, she was CEO of customer services and retention for First National Bank’s home loans division. In 2000 she was appointed acting managing director at the Land Bank, where she was previously general manager of operations. Ms. Memela-Khambula also served as regional manager for People's Bank, where she was responsible for managing 25 branches in three provinces. In 1993 Ms. Memela-Khambula joined Nedcor as its community liaison manager and became branch manager in 1994. Prior to entering banking and finance, Ms. Memela-Khambula served in the office of the former secretary general of the African National Congress (ANC), Cyril Ramaphosa, who was part of the team responsible for drafting the South African constitution. She began her career with the ANC in 1978 in Swaziland, Botswana and Zimbabwe. Ms. Memela-Khambula is currently a member of the board of directors of the Rural Housing Loan Fund, Teba Bank Limited and Lekana, a division of First Rand. She holds a Bachelor of Arts in social science from the University of Swaziland and a Master of Public Administration from the University of Zimbabwe.
 |
Ms. Nayyar is PATH's country programme leader in India. Before joining PATH she worked with the International AIDS Vaccine Initiative (IAVI), where she was India country director and then vice president for country and regional programmes, working both in New Delhi and in New York at the organisation's headquarters. Ms. Nayyar holds a master's degree in population studies from Annamalai University, Tamil Nadu, India, and a bachelor’s degree with honours in English literature from St. Xavier's College, Bombay University. She began her career developing educational tools for kindergarten children and then joined the magazine Parenting as assistant editor. Equipped with editorial and media relations experience, she was responsible for communications and advocacy activities for the South and East Asia Region at the Population Council from 1996 to 2002. During this period she planned and co-coordinated several advocacy and communications projects on reproductive and sexual health issues. She also conducted training programmes for researchers, government agencies and NGOs on reproductive and sexual health communication. She developed publications on emergency contraception, expanded and informed contraceptive choice, and reproductive tract infections (RTIs) and sexually transmitted infections (STIs) for the Population Council and for partner agencies such as the United Nations Population Fund. The government of India printed and distributed some of these publications on emergency contraception and RTIs and STIs to programme managers.
 |
Dr. Profy is the former vice president of Preclinical Development at Endo Pharmaceuticals (formerly Indevus Pharmaceuticals) where he managed the programme for PRO 2000 as well as non-clinical studies for other Indevus programmes. Dr. Profy has published widely on microbicide development and HIV prevention. He managed the drug discovery and development process at Procept, Inc., and he has been involved in drug research as both a principal investigator and research scientist. Prior to his work with Procept, Dr. Profy held key scientific research positions at Repligen Corporation. Dr. Profy received his PhD in bio-organic chemistry from Cornell University.
 |
Dr. Rosenberg has been chief executive officer of IPM since its founding in 2002. From 1999 to 2002 Dr. Rosenberg was the scientific director for the HIV Prevention Trials Network at Family Health International. In that role she managed scientific and operational coordination for domestic and international clinical trials in the prevention of mother-to-child HIV transmission, sexual transmission, and intravenous drug use transmission. From 1987 to 1999 Dr. Rosenberg worked in several capacities at the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. National Institutes of Health (NIH). In her role as senior scientist at the Division of AIDS, she was responsible for HIV-prevention clinical trials in adult populations. As assistant director for prevention research, she coordinated prevention activities in the areas of HIV infection and other sexually transmitted diseases as well as tuberculosis. She represented NIH on the Public Health Service Task Force to Combat Multi-Drug Resistant TB and co-chaired the TB Research Subcommittee. Dr. Rosenberg received her undergraduate degree (AB) in biology and mathematics from Douglass College, Rutgers University; a master’s degree (SM) in epidemiology and a doctoral degree (ScD) in microbiology from the Harvard School of Public Health.
 |
Dr. Sandström serves as the executive director of the Southern African AIDS Trust (SAT), where she fosters regional cooperation in the support of community responses to HIV and AIDS. Dr. Sandström has held a variety of teaching and research positions with Umeå University in Sweden, and has published widely. Before joining SAT, she was counselor of the Swedish-Norwegian HIV and AIDS Team for Africa based in Lusaka, Zambia. Dr. Sandström headed the Division for National Research Cooperation and University Support, where she supported research development in Africa, Asia, and Central and South America through her work with the Swedish International Development Cooperation Agency.
 |
Ms. Yuvaraj is Asia-Pacific regional coordinator for the International Community of Women Living with HIV/AIDS (ICW). She previously served as programme manager for HIV and Sexual Reproductive Health at PATH’s India office. Diagnosed as HIV-positive in 1997, she has played a vital role in broadening political and social responses to the epidemic in India. Ms. Yuvaraj began her work by establishing a local organisation to support others living with HIV in her community, which continues to be a strong and effective programme. Through her participation in various fora that address the involvement of people living with HIV/AIDS, she has been instrumental in mobilising communities to raise their voices, call attention to their needs and concerns, and build supportive environments. During her tenure with the Global Fund to Fight AIDS, Tuberculosis and Malaria as the board representative of the communities’ delegation, she strengthened the delegation’s participation by systematising a selection and induction process, formalising communication, and monitoring the effectiveness of its members. Currently, Ms. Yuvaraj provides technical support to the India Campaign for Microbicides and the Indian National AIDS Control Organisation on the Greater Involvement of People Living with and Directly Affected by HIV/AIDS. She is also a member of the national advisory board of the Indian chapter of the International AIDS Vaccine Initiative and the Indian Council of Medical Research. She is a steering committee member, advising the development of national strategies for phase III of the National AIDS Control Programme in India.
|
